Literature DB >> 17299341

The epidemiology of early childhood hyperopia.

Kristina Tarczy-Hornoch1.   

Abstract

Hyperopia is present in a small proportion of children aged between 6 and 12 months, with ethnicity likely affecting prevalence, and higher prevalences in certain subgroups, especially those with a family history of hyperopia or accommodative esotropia. Around a fifth of children who are hyperopic in infancy go on to develop strabismus, while an unknown proportion develop bilateral ametropic amblyopia; persistent hyperopia appears to be a harbinger of future pathology. Early prophylactic spectacle correction of hyperopia has failed to prevent strabismus in three of four studies, but showed reduced incidence of strabismus in one study, and yielded improved visual acuity outcomes in two studies by one investigator. Currently our ability to detect or measure refractive error with automated instruments easily adaptable to a screening setting has outpaced our knowledge of how best to identify the subset of hyperopes who are really at risk, and how to manage isolated early hyperopia once it has been identified.

Entities:  

Mesh:

Year:  2007        PMID: 17299341     DOI: 10.1097/OPX.0b013e318031b674

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  10 in total

1.  Accommodative lag and refractive error in infants and toddlers.

Authors:  Kristina Tarczy-Hornoch
Journal:  J AAPOS       Date:  2012-03-15       Impact factor: 1.220

2.  Which hyperopic patients are destined for trouble?

Authors:  T Rowan Candy
Journal:  J AAPOS       Date:  2012-04       Impact factor: 1.220

3.  The long-term outcome of the refractive error in children with hypermetropia.

Authors:  Eedy Mezer; Ewy Meyer; Tamara Wygnansi-Jaffe; Wolfgang Haase; Yaacov Shauly; Albert W Biglan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-08       Impact factor: 3.117

4.  Modified bell retinoscopy: measuring accommodative lag in children.

Authors:  Kristina Tarczy-Hornoch
Journal:  Optom Vis Sci       Date:  2009-12       Impact factor: 1.973

5.  Longitudinal changes in refractive error of children with infantile esotropia.

Authors:  E E Birch; D R Stager; J Wang; A O'Connor
Journal:  Eye (Lond)       Date:  2010-10-08       Impact factor: 3.775

Review 6.  Hyperopia: a meta-analysis of prevalence and a review of associated factors among school-aged children.

Authors:  Victor Delpizzo Castagno; Anaclaudia Gastal Fassa; Maria Laura Vidal Carret; Manuel Augusto Pereira Vilela; Rodrigo Dalke Meucci
Journal:  BMC Ophthalmol       Date:  2014-12-23       Impact factor: 2.209

7.  Perception of Trifocal IOL Performance in Young Adults with High Astigmatism and Hyperopia and its Improvement Using Small Incision Lenticule Extraction.

Authors:  Faruk Semiz; Anita Syla Lokaj; Gulser Caliskan; Giuseppe Verlato; Njomza Hima Musa; Ceren Ece Semiz; Zekeriya Alp Demirsoy
Journal:  Acta Inform Med       Date:  2021-06

8.  Whole exome sequence analysis in 51 624 participants identifies novel genes and variants associated with refractive error and myopia.

Authors:  Jeremy A Guggenheim; Rosie Clark; Jiangtian Cui; Louise Terry; Karina Patasova; Annechien E G Haarman; Anthony M Musolf; Virginie J M Verhoeven; Caroline C W Klaver; Joan E Bailey-Wilson; Pirro G Hysi; Cathy Williams
Journal:  Hum Mol Genet       Date:  2022-06-04       Impact factor: 5.121

9.  Evidence for the need for vision screening of school children in Turkey.

Authors:  Serap Azizoğlu; Sheila G Crewther; Funda Şerefhan; Ayla Barutchu; Sinan Göker; Barbara M Junghans
Journal:  BMC Ophthalmol       Date:  2017-12-02       Impact factor: 2.209

10.  Ocular Refraction at Birth and Its Development During the First Year of Life in a Large Cohort of Babies in a Single Center in Northern Italy.

Authors:  Francesco Semeraro; Eliana Forbice; Giuseppe Nascimbeni; Salvatore Cillino; Vincenza Maria Elena Bonfiglio; Maria Elena Filippelli; Silvia Bartollino; Ciro Costagliola
Journal:  Front Pediatr       Date:  2020-01-29       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.